Opus Genetics, Inc.
IRD
$3.84-5.19%
End of day · as of Oct 17, 2026, 2:00 PM ET
Mkt cap
$35.67M
EV/Sales
-0.58
P/E ratio
N/A
FY2025 Revenue
$14.20M
EPS (TTM)
$-1.29
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-349.33%
Beta
0.24
Div yield
N/A
Sector
Healthcare
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported IRD revenue for 2025-12-31 was $14.2M. Net income was -$49.6M. Revenue was up 29.1% from 2024-12-31 to 2025-12-31. IRD currently screens at market cap $35.7M.
Use this IRD research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IRD income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Opus Genetics, Inc. (IRD) is a biotechnology company in the Healthcare sector.
Latest cached Opus Genetics, Inc. (IRD) revenue for Dec 31, 2025 was $14.2M. Net income was -$49.6M. Statements: https://lician.com/financials/ird
Opus Genetics, Inc. (IRD) market capitalization is $35.7M on the latest cached snapshot.
Opus Genetics, Inc. (IRD) cached previous close $4.05; day range $3.79 – $4.12; volume 2,519,839. Session quote: https://lician.com/quote/ird
Opus Genetics, Inc. (IRD) latest cached earnings event is "IRD earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IRD filing is 8-K · Oct 15, 2026. Filings: https://lician.com/sec/ird